Watertown, MA, United States of America

Debra A Willins

This inventor holds 1 USPTO granted patent. Top assignee: Oscient Pharmaceuticals Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Debra A Willins. Retrieved from https://idiyas.com/inventor/debra-a-willins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Debra A. Willins: Innovator in Polypeptide Research

Introduction

Debra A. Willins is a prominent inventor based in Watertown, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides. Her work has implications for therapeutic and diagnostic applications, showcasing her innovative spirit and dedication to scientific advancement.

Latest Patents

Debra holds 1 patent that focuses on the invention of novel polypeptides found on the cell wall of specific organisms. This invention also includes methods for utilizing these polypeptides, as well as the genes encoding them, for the preparation of antibodies, vaccines, and other therapeutic and diagnostic compositions.

Career Highlights

Debra is currently employed at Oscient Pharmaceuticals Corporation, where she continues to push the boundaries of research and innovation. Her expertise in polypeptide research has positioned her as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout her career, Debra has collaborated with notable colleagues, including Arturo Morales and Guillaume Cottarel. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Debra A. Willins exemplifies the spirit of innovation in biotechnology through her research and patent contributions. Her work not only advances scientific knowledge but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…